DUBA antikoerper, AA407879 antikoerper, AI553596 antikoerper, BB114028 antikoerper, DXImx46e antikoerper, Sfc7 antikoerper, otud5 antikoerper, si:bz30i22.1 antikoerper, si:rp71-30i22.1 antikoerper, zgc:154072 antikoerper, wu:fi28a06 antikoerper, zgc:100839 antikoerper, OTU deubiquitinase 5 antikoerper, OTU domain containing 5 antikoerper, OTU deubiquitinase 5a antikoerper, OTU deubiquitinase 5 S homeolog antikoerper, OTU deubiquitinase 5 L homeolog antikoerper, OTU deubiquitinase 5b antikoerper, OTUD5 antikoerper, Otud5 antikoerper, otud5a antikoerper, otud5.S antikoerper, otud5.L antikoerper, otud5b antikoerper
Hintergrund
OTUD5 (ovarian tumor domain-containing 5), also called DUBA (Deubiquitinating enzyme A), is a product of the OTUD5 gene, and a suppressor of the innate immune response via its deubiquitinating activity. The Innate immune systems provide immediate but short-lived defense against infection identified by PRRs, or pattern recognition receptors. OTUD5 cleaves the lysine-63-linked polyubiquitin chains of TRAF3, causing it to dissociate from TBK1, thereby failing to stimulate IFN type 1 production and leading to a suppressed innate immune response.